| Imaging the arterial wall - assessment of risk | | Sechtem, U. Stuttgart, Germany
| | 997000 |
| Variability of repolarisation - a novel biomarker for arrhythmias? Basic Science | | Belardinelli, L. and Shryock, J.C., USA
Volders, P., NL
| | 992000
|
| Coronary artery disease as an immune disease Symposium | | Hasin, J. M.P. Lower Galilee, Israel
| Acute Coronary Syndromes (ACS) | 987000 |
| Novel aspects in management of acute pulmonary embolism, Imaging | | Perrier. Geneva, Switzerland
| | 978000 |
| Dilated aorta in adults with congenital cardiac disease | | Kaemmerer, H. & Popelova, J. Aorta, Germany
| Congenital Heart Disease | 976000 |
| The global health agenda: case for cardiovascular disease Symposium | | Voute, J. Geneva, Switzerland
| Cardiovascular Disease Prevention - Risk Assessment and Management | 970000
|
| From (mal)adaptive hypertrophy to heart failure,Myocardial Disease | | Crozatier, B. Chatenay-Malabry, France
| Myocardial Disease | 964000 |
| Making a heart - from developmental biology to tissue engineering | | Leor, J. Tel Hashomer, Israel
| | 962000
|
| Making a heart - from developmental biology to tissue engineering Basic Science Track | | Leor, J. Tel Hashomer, Israel
| | 962000 |
| Lipids and the elderly - what have we learned? Symposium | | Reiner, Z. Zagreb, Croatia
| Cardiovascular Disease Prevention - Risk Assessment and Management | 952000 |
| New bioimaging methods for the understanding of microvascular function in animals and man - Basic Science | | Pries, A.R. Berlin, Germany
| | 950000 |
| Harvesting the potential of genomics for cardiovascular diseases Basic Science Track | | De Kleijn, D. Singapore
| | 949000
|
| Microvascular structure & function, cell-cell interaction | | Pearson, J. London, United Kingdom
| | 948000 |
| Carotid intima-media thickening, Non-invasive imaging | | Kownator, S. Thionville, France
| | 946000 |
| Assessment of left atrial anatomy and function Symposium | | Popescu, B.A. Bucharest, Romania
| | 940000 |
| Asymptomatic patient with mitral regurgitation Clinical Seminar | | Flachskampf, F.A. Hamburg, Germany
| | 938000
|
| Clinical applications of three-dimensional echocardiography | | Beppu, S. Osaka, Japan
| | 937000
|
| Role of exercise training in chronic heart failure | | Piepoli, M. Piacenza, Italy
| Heart Failure (HF) | 935000
|
| Beneficial effects of physical training in cardiovascular disease | | Ellingsen, O. Trondheim, Norway
| Rehabilitation and Exercise Physiology | 934000
|
| Immunisation against Atherosclerosis – a dream or a reality? Basic Science | | Mach, F.A. Geneva, Switzerland
| | 933000 |
| Inflammatory basis of plaque rupture Symposium | | Jackson, C. Briston, United Kingdom
| Acute Coronary Syndromes (ACS) | 932000
|
| The natural history of Atherosclerosis: the search for the vulnerable patient - Basic Science | | Biessen, E. Leiden, Netherlands
| Chronic Ischaemic Heart Disease (IHD) | 931000 |
| Vasa vasorum, Atherosclerotic plaque, Acute Coronary Syndrome | | Pasterkamp, G. Utrecht, NL
| Acute Coronary Syndromes (ACS) | 930000
|
| Cardiomyopathy, Diagnostic & therapeutic intervention | | Pankuweit, S. Marburg, Germany
| Myocardial Disease | 928000
|
| Hot issues in myocarditis Symposium | | Thiene. Padua, Italy
| | 926000
|
| Lone atrial fibrillation: what should we do? Clinical Seminar | | Obadia, J.-F. Lyon-Bron, France
| | 925000
|
| Hypertrophic cardiomyopathy: new paradigms Clinical Seminar | | Waldenstrom, A. Umea, Sweden
| Myocardial Disease | 924000
|
| Controversial issues in the elderly, CVD Prevention | | Norekval, T.M. Bergen, Norway
| Cardiovascular Disease Prevention - Risk Assessment and Management | 923000
|
| Psychosocial risk factors: how bad are they really for the patient Symposium | | McGee, H. Dublin, Ireland
| | 918000 |
| Challenges of cardiology in Africa, Prevention | | Amoah. Accra, Ghana
| Cardiovascular Disease Prevention - Risk Assessment and Management | 914000 |
| Depression & coronary heart disease: brain-heart interaction | | Tubaro. Rome, Italy
| | 912 000 |
| Indications for cardiac resynchronisation therapy, Arrhythmia | | Linde, C. Stockholm, Sweden
| Arrhythmias | 908000 |
| Novel devices for heart failure Symposium | | Merino, J.L. Madrid, Spain
| | 907000 |
| Interaction of diabetes with antithrombotic agents Symposium | | Andreotti, F. Rome, Italy
| Diabetic heart disease | 903000 |
| Resistance to antiplatelet agents, Clinical pharmacology | | Kristensen, S.D.
Aarhus, Denmark
| Clinical pharmacology | 902000 |
| Endothelial activation, dysfunction and damage - the key to thrombosis? | | Keren, G. Tel-Aviv, Israel
| | 901000
|
| Highlights from EuroPrevent 2006, EACPR, Prevention | | Perk, J. Oskarshamn, Sweden
| Cardiovascular Disease Prevention - Risk Assessment and Management | 734000 |
| Highlights, Euroecho 9, Recent advances in echocardiology | | Nihoyannopoulos, P. London, United Kingdom
| | 732000 |
| Percutaneous coronary interventions in clinical practice in Europe | | Gitt, A.K. Ludwigshafen, Germany
| Acute Coronary Syndromes (ACS) | 727000 |
| Hypertension, diabetes and the heart, Join symposium | | Kjeldsen, S.E. Oslo, Norway
| | 723000 |
| Guidelines for resuscitation | | Capucci, A. Piacenza, Italy
| | 720000 |
| Education and training in cardiology | | Amlie, J.P. Oslo, Norway
| | 717000 |
| Redefinition of myocardial infarction | | Tendera, M. Katowice, Poland
| Acute Coronary Syndromes (ACS) | 715000 |
| Science Hotline - Basic Science | | Pries, A.R. Berlin, Germany
| | 711000 |
| Clinical Trial Update III | | Perez Gomez, F.
Discussant: Daubert
| Atrial Fibrillation | 708003
|
| Clinical Trial Update III | | Gibson
Discussant: Hamm, C.W.
| Acute Coronary Syndromes (ACS) | 708001
|
| Safety of drug-eluting stents: insights from meta analysis. | | Camenzind
Discussant: Nordmann, A.J.
| Acute Coronary Syndromes (ACS) | 707009 |
| New telemonitoring system in chonic heart failure : the HHH Study | | Mortara, A.
Discussant: Swedberg, K.
| Heart Failure (HF) | 707007
|
| EUROACTION: a nurse lead multidisciplinary preventive cardiology programme for coronary patients, high risk individuals and their families. | | Wood
Discussant: Pearson, T.A.
| Cardiovascular Disease Prevention - Risk Assessment and Management | 707003
|
| The perindopril in elderly people with chronic heart failure (PEP-CHF) study. | | Cleland.
Discussant: Dickstein, K.
| Valvular Heart Diseases | 707001 |
| Principal outcomes of Raloxifene therapy in postmenopausal women at risk of major coronary events: Raloxifene use for the heart (RUTH) Trial. | | Collins, P.
| Cardiovascular Disease Prevention - Risk Assessment and Management | 706012 |
| The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study. | | Amarenco, P.
| Cardiovascular Disease Prevention - Risk Assessment and Management | 706011 |
| Homocysteine lowering in chronic stable vascular disease, the HOPE-2 Trial. | | Lonn, E. Dicussant: Hall, R.
| Cardiovascular Disease Prevention - Risk Assessment and Management | 706009
|
| A prospective, multicenter, randomised, double-blind, placebo-controlled trial to evaluate the efficacy of patients foramen ovale closure with the STARFlex septal repair implant to prevent refractory migraine headaches: the MIST Trial. | |
Dowson.
Discussant: Eeckhout, E.
| Cardiovascular Disease Prevention - Risk Assessment and Management | 706007 |
| Glucose-Insulin and potassium in STEMI patients: results of OASIS 6 study and a combined analysis with CREATE-ECLA trial. | | Diaz, R.
| Acute Coronary Syndromes (ACS) | 706005
|
| Important worldwilde differences in outcomes among atherothrombotic patients: results from Reduction in Atherothrombotic for Continued Health (REACH) Registry. | | Ohman, M.
| | 706003 |
| Effect of Pioglitazone in stroke prevention in type 2 diabetes: a prespecified subgroup analysis of PROactive. | | Wilcox, R.G.
| Cardiovascular Disease Prevention - Risk Assessment and Management | 706001
|
| Signal transduction in myocardial ischaemia Symposium | | Valen, G. Oslo, Norway
| | 178000 |
| Differential diagnoses of elevated cardiac troponins Symposium | | Galvani, M. Forli, Italy
| Acute Coronary Syndromes (ACS) | 170000 |
| Valve surgery in the elderly Main Session | | Nojek, C.A. Buenos Aires, Argentina
| Valvular Heart Diseases | 167000
|
| Towards less invasive treatment for valve disease Symposium | | Rosenhek, R. Wien, Austria
| Valvular Heart Diseases | 166000 |
| Endocarditis - the essentials in a dangerous disease | | Rahimtoola, S. Los Angeles, United States
| Infective Endocarditis | 165000 |
| Current status of novel antihypertensives Symposium | | Heagerty, A. Manchester, United Kingdom
| Hypertension | 164000
|
| How to protect the ageing heart Symposium - Bench to Bedside | | Gillebert, T.C. Gent, Belgium
| Cardiovascular Disease Prevention - Risk Assessment and Management | 161000
|
| Echocardiographic measurements in heart failure Symposium | | Zamorano Gomez, J.L. Madrid, Spain
| | 158000 |
| Left-ventricular remodelling Symposium | | Hess, O.M. Bern, Switzerland
| | 157000
|
| Tricuspid valve regurgitation and repair Symposium | | Alfieri, O. Milano, Italy
| Valvular Heart Diseases | 155000
|
| Patent foramen ovale (PFO), Congenital Heart Disease | | Eberli, F.R. Zurich, Switzerland
| Congenital Heart Disease | 152000
|
| Evaluation of multivessel disease Symposium | | Weidinger, F. Innsbruck, Austria
| Invasive Imaging: Cardiac Catheterisation and Angiography | 151000 |
| Heart failure in the elderly: an epidemic for the 21st century | | McMurray, J. Glasgow, United Kingdom
| Heart Failure (HF) | 149000
|
| Coronary microvascular dysfunction Symposium | | Ambrosio, G. Perugia, Italy
| Chronic Ischaemic Heart Disease (IHD) | 142000
|
| What limits exercise capacity in heart failure? | | Piepoli, M. Piacenza, Italy
| Heart Failure (HF) | 138000 |
| Tissue characterisation by cardiac magnetic resonance, Imaging | | Lombardi, M. Pisa, Italy
| | 135000 |
| Aldosterone receptor antagonism: mechanisms and targets | | Richard, S. Montpellier, France
| | 129000
|
| Heart failure with normal ejection fraction: controversy continues! | | Escobar, E. Santiago, Chile
| Heart Failure (HF) | 128000 |
| Heart failure with preserved systolic function | | Metra, M. Brescia, Italy
| Heart Failure (HF) | 126000 |
| Debated issues in genetic diseases, Sudden death | | Blomstrom-Lundqvist, C. Uppsala, Sweden
| Sudden Cardiac Death and Resuscitation | 123000 |
| Atrial fibrillation and heart failure Symposium | | Raviele, A. Mestre, Italy
| Atrial Fibrillation | 121000
|
| Antithrombotic therapy in atrial fibrillation Symposium | | Lip, G.Y.H. Birmingham, United Kingdom
| Atrial Fibrillation | 120000 |
| Management of atrial fibrillation in an ageing population Symposium | | Le Heuzey, J.-Y. Paris, France
| Atrial Fibrillation | 119000 |
| Rhythm device recalls: time for clarification Symposium | | Kappenberger, L. Lausanne, Switzerland
| Arrhythmias | 117000
|
| Indications for implantable cardioverter-defibrillators | | Farre. Madrid, Spain
| Arrhythmias | 114000 |
| Clinical & electrocardiographic predictors, sudden death in athletes | | Bjornstad, H. Bergen, Norway
| Sudden Cardiac Death and Resuscitation | 113000
|
| Cardiovascular adverse effects of doping in sports Symposium | | Furlanello, F. & Deligiannis, A.
| Rehabilitation and Exercise Physiology | 112000 |
| Positron emission tomography, Non-invasive imaging | | Bottcher, M. Aarhus, Denmark
| | 110000 |
| Screening for coronary artery disease, asymptomatic & high-risk | | Kiess, M. Vancouver, Canada
| Chronic Ischaemic Heart Disease (IHD) | 108000
|
| Treatment of cachectic patients, Reverse cachexia | | Piepoli, M. Piacenza, Italy
| | 106000
|
| Novel sources of stem cells Basic Science Track | | Emanueli, C. Bristol, United Kingdom
| | 105000 |
| Cardiac and vascular repair by stem cells: find them and apply them - Basic Science | | Angelini, A. Padova, Italy
| | 104000 |
| Wine and cardiovascular diseases, Prevention | | Weis, M. Munchen, Germany
| Cardiovascular Disease Prevention - Risk Assessment and Management | 989000 |
| Genetic defects in calcium handling and arrhythmias Symposium | | Schulze-Bahr, E. Munster, Germany
| Arrhythmias | 965000 |
| Treatment in different forms of pericarditis Symposium | | Soran, O. Pittsburgh, United States
| Pericardial Disease | 927000 |
| New concepts in the treatment of aortic valve disease Symposium | | Maisano, F. Milan, Italy
| Valvular Heart Diseases | 920000 |
| Community initiatives: Reduce the burden of cardiovascular disease | | Volqvartz. Copenhagen, Denmark
| Cardiovascular Disease Prevention - Risk Assessment and Management | 915000 |
| Metabolic syndrome - a myth or useful concept ? | | Pyorala, K. Kuopio, Finland
| | 719000
|
| Peripheral artery disease for the cardiologist Clinical Seminar - The European Society of Cardiology and the World Heart Federation | | Oto, A. Ankara, Turkey
| Peripheral Arterial Diseases | 718000 |
| Developments in the European Union on diet and physical activity | | Logstrup, S. Brussels, Belgium
| Cardiovascular Disease Prevention - Risk Assessment and Management | 716000 |
| Telemedicine for prehospital management of heart attack | | Van der Velde, E.
Leiden, The Netherlands
| Acute Coronary Syndromes (ACS) | |
| Lipid Research and where we go from here - Basic Science | | Reiner, Z. Zagreb, Croatia
| | |
| Clinical Trial Update III | |
De Winter, R.J. | Acute Coronary Syndromes (ACS) | |
| Clinical Trial Update III | | Widimsky, P.
Discussant: Gitt, A.K.
| Acute Coronary Syndromes (ACS) | |
| Clinical Trial Update III | |
Lagerqvist, B. | Acute Coronary Syndromes (ACS) | |
| Warafarin Antiplatelet Vascular Evaluation (WAVE): a randomized controlled trial testing moderate intensity oral anticoagulation and antiplatelets therapy vs antiplatelet therapy alone in patients with peripheral arterial disease. | |
Anand
Discussant: Verheugt, F.W.A. | | |
| SPIRIT II Study: a clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo, native coronary artery lesions. | |
Serruys, P. | | |
| Early and long-term outcome of elective stenting of the infarct-related artery in patients with viability in the infarct-area. (The Viability-guided angioplasty after acute myocardial infarction trial). The VIAMI Trial. | | Veen, G
Discussant: Di Mario, C.
| Myocardial Disease | |
| The Thrombolysis in Cardiac Arrest (TROICA) Trial. | |
Boettiger, B.W. | | |
| Cardiovascular disease prevalence and relationship with waist circumference (WC) in Asian versus European primary care patients: the International Day for the Evaluation of Abdominal Obesity (IDEA) study. | |
Bassand*, J.-P.
Discussant: Tuomilehto, J. | | |
| DES versus BMS: an evidence-based approache to stent selection in real-world" patients: 18 month update of BASKET." | | Kaiser, C.
Discussant: Marco, J.
| Acute Coronary Syndromes (ACS) | |
| Determinants of new onset diabetes among hypertensive patients randomised in the ASCOT-BPLA Trial. | | Gupta, A.
Discussant: Zamorano Gomez, J.L.
| Hypertension | |
| A randomized study with the sirolimus coated BXTM velocityTM balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. The RAVEL study. | |
Morice, M.C.
Discussant: De Bruyne | Acute Coronary Syndromes (ACS) | |
| Effect on mode and cause of death of initiation of treatment for chronic heart failure with bisoprolol followed by additionnal enalapril compared to the opposite sequence: results of the randomized CIBIS-III trial. | | Willenheimer, R.
Discussant: Tavazzi, L.
| Heart Failure (HF) | |
| Overview of large randomised trials of angiotensin-converting enzyme inhbitors in patients with stable vascular disease without left ventricular systolic dysfunction or heart failure in the context of previous large trials. | |
Dagenais, G.R. | Clinical pharmacology | |